Current Research Projects

Ongoing Research Projects:

  • Establishment of Intra-brain Stem Xenograft Mouse Models and Permanent Cell Cultures of DIPG
  • Patterns of cerebrospinal fluid diversion and survival in children with diffuse intrinsic pontine glioma
  • Diffuse Intrinsic Pontine Glioma (DIPG): the Australian Experience
  • Re-irradiation of children with DIPG: practices and outcomes
  • Characterizing temporal genomic heterogeneity in pediatric DIPG
  • Elucidating lipid metabolic reprogramming in Diffuse Intrinsic Pontine Glioma
  • Novel target discovery in Diffuse Midline Glioma
  • Outcomes for children with spinal diffuse midline gliomas (sDMG): a DIPG Registry Study
  • Clinical, Radiological, Histological, and Molecular Characteristics of Patients with Midline Gliomas in Canada
  • Timing of Radiation Therapy Initiation and Association with Neurological Recovery in Patients with New Diagnosis of DIPG
  • Evaluation of the distribution and correlates of post-radiation and best responses over time in patients with diffuse intrinsic pontine glioma (DIPG): A IDIPGR Study
  • Clinical, Radiographic, Histopathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma-an Update from the International and European Society for Pediatric Oncology DIPG Registries
  • Initial and early metastatic spread in diffuse midline glioma, H3 K27-altered; Potential implications for diagnostic workup and treatment
  • Racial and Ethnic Biases in Patients enrolled in the International DIPG/DMG Registry: Addressing demographic representativeness and barriers to research participation
  • Comprehensive untargeted metabolomics profiling of diffuse midline glioma for biomarker discovery and therapeutic targets
  • Using AI to help with diagnosis, volumetric analysis and the molecular classification of primary pediatric CNS Tumors
  • Predicting Early Death in Children diagnosed with Diffuse Midline Glioma

Completed Research Projects:

  • Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology
  • Radiogenomic Evaluation of Radiation Resistance in Diffuse Intrinsic Pontine Glioma
  • A safety run-in, phase 2 trial of Convection Enhanced Delivery (CED) of Carboplatin and Sodium Valproate into the pons for the treatment of Diffuse Intrinsic Pontine Glioma (DIPG) after radiotherapy in children aged 3-17 years
  • STAT3 expression in patients with diffused intrinsic pontine glioma

Manuscripts Published:

To submit a research proposal please contact the Registry office.

Or access the application here.